Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael L. Babich currently holds 421,572 shares of Insys Therapeutics, Inc. (INSY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael L. Babich has been a net seller of INSY stock. They have purchased $38.6K and sold $29.8M worth of shares.
Michael L. Babich's most recent insider trade was on Sep 22, 2015, when they sold 16,068 shares at $1.62 per share.
Michael L. Babich serves as Executive at Insys Therapeutics, Inc. (INSY). They have executed 44 insider transactions totaling $29.8M over their tenure at the company.
Michael L. Babich holds the position of Executive at Insys Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Michael L. Babich has shown a selling trading pattern, with $38.6K in total purchases and $29.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael L. Babich was on Mar 5, 2014, when they sold $13.6M worth of INSY shares. This transaction involved 187,211 shares at $72.65 per share.
Michael L. Babich currently owns 421,572 shares of Insys Therapeutics, Inc. (INSY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael L. Babich's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael L. Babich has 44 Form 4 filings on record as an insider at Insys Therapeutics, Inc..
Set alerts for Michael L. Babich and 40,000+ other insiders.